TMEM247
gene geneOn this page
Summary
TMEM247 (transmembrane protein 247, HGNC:42967) is a protein-coding gene on chromosome 2p21, encoding Transmembrane protein 247 (A6NEH6).
Predicted to be located in membrane. Predicted to be active in endoplasmic reticulum.
Source: NCBI Gene 388946 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 38 total
- MANE Select transcript:
NM_001424184
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:42967 |
| Approved symbol | TMEM247 |
| Name | transmembrane protein 247 |
| Location | 2p21 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000284701 |
| Ensembl biotype | protein_coding |
| Entrez | 388946 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000434431
RefSeq mRNA: 1 — MANE Select: NM_001424184
NM_001424184
CCDS: CCDS56117
Canonical transcript exons
ENST00000434431 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001382764 | 46480405 | 46480764 |
| ENSE00001696881 | 46479565 | 46479702 |
| ENSE00001774845 | 46484244 | 46484425 |
Expression profiles
Bgee: expression breadth broad, 16 present calls, max score 90.56.
Top tissues by expression
103 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 90.56 | gold quality |
| left testis | UBERON:0004533 | 90.52 | gold quality |
| testis | UBERON:0000473 | 89.79 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.93 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.75 | gold quality |
| placenta | UBERON:0001987 | 65.04 | gold quality |
| sural nerve | UBERON:0015488 | 44.91 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| right coronary artery | UBERON:0001625 | 31.39 | silver quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.50 | gold quality |
| urinary bladder | UBERON:0001255 | 29.35 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.26 | gold quality |
| tonsil | UBERON:0002372 | 28.75 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| monocyte | CL:0000576 | 27.88 | gold quality |
| leukocyte | CL:0000738 | 27.86 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| blood | UBERON:0000178 | 26.48 | gold quality |
| muscle of leg | UBERON:0001383 | 26.48 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem247 | ENSMUSG00000037689 |
| rattus_norvegicus | Tmem247 | ENSRNOG00000046926 |
Protein
Protein identifiers
Transmembrane protein 247 — A6NEH6 (reviewed: A6NEH6)
All UniProt accessions (1): A6NEH6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_001411113* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029200 | TMEM247 | Family |
Pfam: PF15444
UniProt features (7 total): transmembrane region 2, compositionally biased region 2, chain 1, region of interest 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NEH6-F1 | 67.50 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 10 (showing top):
GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN, GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP, GSE22045_TREG_VS_TCONV_UP, GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP, GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP, chr2p21, GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN, GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN, GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN, GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): endoplasmic reticulum (GO:0005783), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
218 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM247 | ATP6V1E2 | Q96A05 | 724 |
| TMEM247 | CRIPT | Q9P021 | 690 |
| TMEM247 | RHOQ | P17081 | 560 |
| TMEM247 | PIGF | Q07326 | 560 |
| TMEM247 | PRR22 | Q8IZ63 | 553 |
| TMEM247 | STPG4 | Q8N801 | 541 |
| TMEM247 | ZNF583 | Q96ND8 | 512 |
| TMEM247 | TRIM67 | Q6ZTA4 | 507 |
| TMEM247 | WDR89 | Q96FK6 | 478 |
| TMEM247 | UQCC6 | Q69YU5 | 473 |
| TMEM247 | ANKH | Q9HCJ1 | 458 |
| TMEM247 | ACTRT2 | Q8TDY3 | 452 |
| TMEM247 | CCDC81 | Q6ZN84 | 445 |
| TMEM247 | ZFAND2A | Q8N6M9 | 425 |
| TMEM247 | DUS3L | Q96G46 | 419 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2AFS9, A6H754, A6NC78, A6NEH6, A6NFA0, A6NMD2, A7E2F4, A8MVX0, B2RQL2, D2HQI1, D6RF30, H3BQL2, P0CJ92, P0DX53, P24001, Q14BK3, Q1RN00, Q2YDG1, Q32KP7, Q32LI3, Q3B8N5, Q3T020, Q3TCJ8, Q497K7, Q497N6, Q642A3, Q66HF0, Q68US1, Q6AXN6, Q6GVM5, Q6K1E7, Q6ZVD7, Q7L3B6, Q7L4S7, Q7Z572, Q80VY2, Q86WR6, Q8BII1, Q8BW86, Q8N6T0
Diamond homologs: A6NEH6, Q2YDG1, Q497K7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
38 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 35 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
312 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:46479684:G:T | donor_gain | 0.9900 |
| 2:46480760:GCCTG:G | donor_gain | 0.9900 |
| 2:46480762:CTGGT:C | donor_loss | 0.9900 |
| 2:46480763:TGGT:T | donor_loss | 0.9900 |
| 2:46480765:G:GC | donor_loss | 0.9900 |
| 2:46480778:A:T | donor_gain | 0.9900 |
| 2:46482574:A:T | donor_gain | 0.9900 |
| 2:46484242:A:AC | acceptor_loss | 0.9900 |
| 2:46484242:A:AG | acceptor_gain | 0.9900 |
| 2:46484243:G:GT | acceptor_gain | 0.9900 |
| 2:46484243:GT:G | acceptor_gain | 0.9900 |
| 2:46479684:G:GT | donor_gain | 0.9800 |
| 2:46480399:C:G | acceptor_gain | 0.9800 |
| 2:46480767:GGGT:G | donor_loss | 0.9800 |
| 2:46480768:GGTGA:G | donor_loss | 0.9800 |
| 2:46480777:G:GT | donor_gain | 0.9800 |
| 2:46484238:CCACA:C | acceptor_gain | 0.9800 |
| 2:46484239:CACAG:C | acceptor_gain | 0.9800 |
| 2:46484240:ACAGT:A | acceptor_gain | 0.9800 |
| 2:46484241:C:G | acceptor_gain | 0.9800 |
| 2:46484241:CAGT:C | acceptor_gain | 0.9800 |
| 2:46484243:GTT:G | acceptor_gain | 0.9800 |
| 2:46484243:GTTTT:G | acceptor_gain | 0.9800 |
| 2:46480401:CCAGG:C | acceptor_gain | 0.9700 |
| 2:46480685:T:TA | donor_gain | 0.9700 |
| 2:46480686:G:GA | donor_gain | 0.9700 |
| 2:46480765:G:GG | donor_gain | 0.9700 |
| 2:46484240:A:AG | acceptor_gain | 0.9700 |
| 2:46484242:AG:A | acceptor_gain | 0.9700 |
| 2:46484243:G:T | acceptor_gain | 0.9700 |
AlphaMissense
1437 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:46480624:T:C | F113L | 0.966 |
| 2:46480626:C:A | F113L | 0.966 |
| 2:46480626:C:G | F113L | 0.966 |
| 2:46480631:T:C | L115P | 0.964 |
| 2:46480640:T:C | L118P | 0.962 |
| 2:46484304:T:C | C180R | 0.953 |
| 2:46484339:G:C | K191N | 0.949 |
| 2:46484339:G:T | K191N | 0.949 |
| 2:46484379:T:C | C205R | 0.941 |
| 2:46480616:G:C | R110P | 0.935 |
| 2:46484376:T:C | F204L | 0.932 |
| 2:46484378:C:A | F204L | 0.932 |
| 2:46484378:C:G | F204L | 0.932 |
| 2:46484307:T:C | F181L | 0.931 |
| 2:46484309:C:A | F181L | 0.931 |
| 2:46484309:C:G | F181L | 0.931 |
| 2:46480637:G:C | R117P | 0.921 |
| 2:46484286:T:C | F174L | 0.911 |
| 2:46484288:T:A | F174L | 0.911 |
| 2:46484288:T:G | F174L | 0.911 |
| 2:46484319:C:G | H185D | 0.911 |
| 2:46484411:A:C | K215N | 0.909 |
| 2:46484411:A:T | K215N | 0.909 |
| 2:46484352:T:C | F196L | 0.903 |
| 2:46484354:T:A | F196L | 0.903 |
| 2:46484354:T:G | F196L | 0.903 |
| 2:46480649:T:C | L121P | 0.901 |
| 2:46480620:G:A | M111I | 0.900 |
| 2:46480620:G:C | M111I | 0.900 |
| 2:46480620:G:T | M111I | 0.900 |
dbSNP variants (sampled 300 via entrez): RS1000983770 (2:46480460 C>A,G,T), RS1001106785 (2:46477609 C>T), RS1001514404 (2:46484488 A>C,T), RS1002127666 (2:46484248 C>G,T), RS1002459724 (2:46479973 T>A), RS1002792352 (2:46482044 A>G,T), RS1003028470 (2:46483134 T>C), RS1003333527 (2:46478955 A>C), RS1003854732 (2:46481064 G>C), RS1004857136 (2:46482313 T>C), RS1005020063 (2:46478871 C>A), RS1005395748 (2:46478616 GGT>G), RS1005408905 (2:46477959 T>C), RS1005476765 (2:46480961 G>A), RS1005528831 (2:46480349 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-palmitoylglycerol | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.